Diagnostic value of microRNAs in prostate cancer patients with prostate specific antigen (PSA) levels between 2, and 10 ng/mL

OBJECTIVE: Prostate specific antigen (PSA), used for the early diagnosis of prostate cancer (PCa), is one of the best tumour markers known so far. However, in situations when PSA is between 2–10 ng/mL, which is named as grey zone, PSA falls short of distinguishing benign prostate diseases from PCa....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Turk J Urol
Egile Nagusiak: Akbayır, Serin, Muşlu, Necati, Erden, Sema, Bozlu, Murat
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Turkish Association of Urology 2016
Gaiak:
Urooncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5125738/
https://ncbi.nlm.nih.gov/pubmed/27909617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tud.2016.52463
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak